NCT06761599View on ClinicalTrials.gov

Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma

Active, not recruitingOBSERVATIONAL
Enrollment

214

Participants

Timeline

Start Date

February 18, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

March 1, 2025

Conditions
Hodgkin Lymphoma
Interventions
DIAGNOSTIC_TEST

group 1

To determine treatment-induced pulmonary toxicity prevalence and risk factors in Hodgkin lymphoma patients during chemotherapy or radiation therapy.

Trial Locations (1)

Unknown

Shaukat Khanum Memorial Cancer Hospital and Research Centre, 5-B, Sector A2, Phase 5, Hayatabad, Peshawar

All Listed Sponsors
lead

Superior University

OTHER